Heterogeneous Reduction in Paediatric RSV Hospitalisations Following Regional Nirsevimab Immunisation Strategies: A Multicentre Study

Study limitation reported by the research below: “Group F data come from a single centre — findings for that group should be interpreted cautiously.”